Register Free at http://www.pharmexec.com/comparative Event Overview: Comparative effectiveness research (CER) has gained a prominent place within the research community and has now become a buzz word within the healthcare industry. Given the heterogeneity of such research and its applicability to a wide range of stakeholders, it is highly relevant to discuss the latest development in this field, including the importance of guidelines by which to evaluate the quality of research. Key Learning Objectives: Specifically, this webcast will briefly describe the: Prospective/Retrospective Study Designs Problem of confounding Representativeness of real world data vs. clinical/registration trials Do Nots of presenting CER data analyses results For questions, contact Sara Barschdorf at sbarschdorf@advanstar.com Who Should Attend: HEOR specialists from any organization, and other professionals from pharmaceutical and medical device companies Presenters: Rahul Dhanda, PhD Director of Health Economics and Outcomes Research McKesson Moderator: Benjamin Comer Senior Editor Pharmaceutical Executive